Public-private collaboration receives grant for research on

Health~Holland has awarded close to € 800,000 to a public-private partnership between UMC Utrecht, Artizan Biosciences, Inc. (USA) and MicroViable Therapeutics (Spain) to unravel how the intestinal microbiota can be exploited to boost cancer immunotherapy and limit therapy side-effects.

Related Keywords

United States , Netherlands , Holland , Artizan Biosciences , Emily Henderson , Health Holland , Artizan Biosciences Inc , Department Of Medical Microbiology , Professor Of Microbiome Research , Microviable Therapeutics , Marcel De Zoete , Medical Microbiology , Associate Professor , Microbiome Research , Cancer , Research , Bacteria , Ancer Immunotherapy , Fell , Immunotherapy , Inflammation , Icrobiology , Icrobiome , T Cell , Herapeutics , Humor ,